Atlas Trials

National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple Sclerosis

Clinical trial NCT02937285 · COMPLETED

Trial details

NCT number
NCT02937285
Sponsor
Rennes University Hospital
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2010-12-06
Primary completion
2020-05-28
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.